Observed Signal · Oct 6, 2026 · Strategy Update · Source: Digiday · Impact: 3/5 · Sentiment: Positive
Consumer Healthcare Brands Embrace CPG Media Strategies
Consumer healthcare brands are increasingly adopting CPG-style media strategies to adapt to shifting consumer behavior and regulatory changes favoring OTC drugs. OTC sales rose to $58.2 billion in 2025, and the FDA has signaled openness to more prescription-to-OTC switches. Opella, spun out of Sanofi, exemplifies this trend, investing heavily in retail media, creator marketing, paid social, and search, with 60% of media investments now in digital channels. The company has built an 85-person in-house team using generative AI for creative production and brought programmatic and search in-house to boost ROI. Other companies like Kenvue and Hims & Hers are also adopting similar approaches. The shift brings challenges, including navigating retail media frictions and balancing long-term brand building with measurable performance, a balancing act CPG marketers already struggle with. AI search is also emerging as a key gateway to health information, requiring brands to monitor LLM citations.
The shift of consumer healthcare brands towards CPG-style media strategies signifies a major evolution in the pharma marketing landscape, with significant implications for retail media, creator marketing, and digital investment. It highlights growth in retail media and AI-driven creative production, making it relevant for AdTech and MarTech stakeholders seeking to understand emerging budget flows and channel priorities.
Track Sanofi Signals & Market Shifts in Real-Time
Polaris7 autonomous intelligence agents track regulatory filings, primary sources, executive changes, and deal flow 24/7. Create your free Explorer workspace to monitor these entities.
Key Takeaways & Evidence Grounding
- OTC sales rose to $58.2 billion in 2025, up from $44.3 billion in 2024.
- Opella, spun out of Sanofi, invests 60% of media in digital channels.
- Opella's e-commerce sales grew from 4% to 12% of revenue in three years.
- Opella built an 85-person in-house team for AI-driven creative production.
- Pharma digital ad spend forecast to reach $26.3 billion this year.
Connected Companies & Entities
7 Entities mapped“Opella was spun out of Sanofi, which retains a 48% stake....”
“Fellow pharma spin-out Kenvue is also competing for market share....”
“DTC healthcare firm Hims & Hers ran a Super Bowl ad in February....”
“Gonzalo Balcazar, formerly of Reckitt, was made president of Europe and Latin America at Opella....”
“Mentioned as a CPG firm that laid the trail for in-house AI creative production....”
“Albert Hernandez spent 17 years at Nestlé before joining Sanofi's consumer business....”
Ontology Mapping & Concepts
Related Market Signals & Shifts
Recent verified developments and strategic activity across this market segment.
Pharma advertisers adopt specialized ad tech
Pharmaceutical marketers are increasingly shifting ad dollars from traditional TV to digital channels and adopting specialized ad tech built for healthcare’s regulatory and privacy constraints. Industry data cited in the article forecasts healthcare and pharma digital ad spending at $26.2 billion versus $6.9 billion for traditional media, with social surpassing linear TV in 2025. Sources tell Digiday that niche vendors such as DeepIntent, Patient Point and Pulsepoint are winning share from legacy DSPs. DeepIntent, after a majority-stake sale to Vitruvian Partners for $637 million in late 2025, unveiled a healthcare-focused agentic AI product called Helix AI and new tools to buy premium live-streaming TV inventory, touting partnerships with major broadcasters and sports-rights holders. Agency and ad buyers say evolving FDA and state-level regulations are driving privacy‑forward targeting and measurement approaches.
Brand Builders Return to CPG Marketing
Digiday's Future of Marketing briefing reports a shift in CPG hiring and strategy away from a performance-only focus toward traditional brand building. Recent CMO hires and role creations — at Smuckers, Hormel and Burger King — reflect demand for executives with brand stewardship experience rather than purely programmatic or lower-funnel skills. The piece argues the performance-first era left many brands with weakened equity as pricing pressure, stagnant volume and private-label gains have reduced margins and growth. Analysts and agency leaders cited in the briefing point to connected TV, fragmented social channels and retail media networks as both a challenge and an opportunity for brand-focused marketing. The newsletter also lists related platform and industry signals, including OpenAI ad products and platform metrics for ChatGPT, Snap and Roku.
Mid-Tier Marketers Scale AI Creative Production
Wyndham Hotels, Opella, and BetMGM are scaling AI-driven creative production, signaling that such capabilities are moving beyond industry giants like Unilever and L'Oréal. These mid-tier advertisers are building in-house teams using AI to mass-produce digital assets, leveraging platforms like Brandtech Group's Pencil and Adora, or developing bespoke internal systems. Wyndham reports a 15x increase in asset output and a 75% reduction in production time, while Opella produces 20x more content and BetMGM uses AI for imagery and video spots in a regulated category. The trend is driven by falling compute costs, improved tool reliability, and competitive pressure, with 81% of CMOs expecting to produce significantly more content. Despite adoption, brands maintain human oversight for certain elements like betting odds or medical professionals, and still rely on agencies for larger campaigns.
Track Real-Time Market Signals & Shifts
Set up custom watchlists to receive automated, evidence-grounded executive digests whenever material signals or shifts occur across your tracked landscape.